GB2025936A - 1,2,3,4-Tetrahydropyrrolo-[1,2-a]- pyrazine and Method for Preparing Same - Google Patents
1,2,3,4-Tetrahydropyrrolo-[1,2-a]- pyrazine and Method for Preparing Same Download PDFInfo
- Publication number
- GB2025936A GB2025936A GB7830788A GB7830788A GB2025936A GB 2025936 A GB2025936 A GB 2025936A GB 7830788 A GB7830788 A GB 7830788A GB 7830788 A GB7830788 A GB 7830788A GB 2025936 A GB2025936 A GB 2025936A
- Authority
- GB
- United Kingdom
- Prior art keywords
- pyrazine
- tetrahydropyrrolo
- hydrogen
- hydrogenation
- desired product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
1,2,3,4-tetrahydropyrrolo-[1,2-a]- pyrazine of the formula: <IMAGE> A method for preparing 1,2,3,4- tetrahydropyrrolo-[1,2-a]-pyrazine which comprises reducing 3,4- dihydropyrrolo-[1,2-a]-pyrazine, in a medium of an organic solvent, by way of hydrogenation with hydrogen or complex hydrides of metals. In the case of using hydrogen said hydrogenation is effected in the presence of a catalyst of the group of platinum. The desired product is then isolated from the reaction mixture. The resulting 1,2,3,4- tetrahydropyrrolo-[1,2-a]-pyrazine may be used as the starting product for the synthesis of physiologically active compounds such as octahydropyrrolo-[1,2-a]-pyrazine which serves as the basis for the preparation of coronary-dilating and neuroleptic medicated compounds.
Description
SPECIFICATION 1 ,2,3,4-Tetrahydropyrrolo- [1 ,2-a]-Pyrazine and Method for Preparing Same
The present invention relates to a novel compound 1 ,2,3,4-tetrahydropyrrolo-[ 1 ,2a]pyrazine and a method for preparing same.
Said novel compound is useful as the starting product for the synthesis of various physiologically active compounds, in particular for the synthesis of octahydropyrrolo-[1 ,2-a]- pyrazine which serves as the basis for the preparation of a coronary-dilating compound 10 (p-[Nil ,4-diazabicyclo(4,3,0)nonanyl/propionyl] i-2-chlorophenothiazine dichlorohydrate and a neuroleptic compound y [N-/l ,4-diazabicyclo-(4,3,0)-nonanylA-propyl- para-fluorophenyl ketone dichlorohydrate.
It is an object of the present invention to provide such a novel compound, i.e. 1,2,3,4tetrahydropyrrolo-[1 ,2-a]-pyrazine which, when used as the starting product, would enable the production, in a simple and efficaceous manner, of the above-mentioned physiologically active compounds.
The novel compound according to the present invention is a hitherto unknown compound, i.e.
1 ,2,3,4-tetrahydropyrrolo-[1 ,2a]-pyrazine having the following structural formula:
1 ,2,3,4-Tetrahydropyrrolo-[l ,2-a]-pyrazine is a colourless liquid with the amine odour and boiling point of 100--101 OC/7 mm Hg, n2g=1.5530. The structure of the resulting compound is proven by the data of elemental analysis of the base and salts, as well as by spectra of proton-magnetic resonance (PMR) and massspectrum. In the PMR spectrum there is a singlet at 1.56 m.d. (scale 8, internal reference by tetramethylsilane) corresponding to one proton of the NH-group, two triplets centered at 2.86 m.d. and 3.63 p.p.m.
corresponding to four protons at C3 and C4 carbon atoms; a singlet at 3.8 p.p.m. corresponding to two protons at the atoms of carbon C ; and three multiplets within the range of from 5.56 to 5.7 p.p.m.; 5.86-6.0 p.p.m.; 6.23-6.37 p.p.m.
corresponding to three protons at carbon atoms C6, C7 and C8. The integral curve corresponds, in to to, to ten protons and its pattern corresponds to the formula given hereinbefore for the compound according to the present invention. Individual character of the compound is proven by the gaschromatography method and its molecular weight is determined from the data of massspectrography showing that M+ has m/e of 122.
In accordance qith the present invention, the method for preparing 1,2,3 ,4-tetrahyd ropyrrolo- [1,2-a]-pyrazine consists in that 3,4 dihydropyrrolo-[1 ,2-a]-pyrazine is subjected to reduction, in a medium of an organic solvent, by way of hydrogenation with hydrogen or complex hydrides of metals; in the case of using hydrogen, said hydrogenation is effected in the presence of a catalyst pertaining to the group of platinum; followed by isolation of the desired product from the resulting reaction mixture.
As the compex hydrides of metals use may be made of various complex hydrides of metals which reduce the double bond C=N in Schiff's bases. It is preferable to use readily available and widely employed for such reaction lithium alumohydride and boronhydrides of sodium and potassium.
In effecting the reduction by way of a catalytic hydrogenation or by means of potassium boron hydride, it is advisable to use, as the organic solvent, lower aliphatic alcohols. Most preferable are methanol and ethanol. In reduction by means of lithium alumohydride it is advisable to use aliphatic ethers or cyclic ethers. Most preferable is diethyl ether.
In the method according to the present invention use may be made of the platinum group catalysts which are employed for hydrogenation of the double bond C=N in Schiff's bases. First of all, for the process according to the present invention use may be made of readily available platinum and palladium catalysts prepared by conventional techniques or platinum and palladium catalysts prepared on carriers (e.g. a platinum catalyst prepared according to Adams; palladium catalyst supported on barium sulphate).
In the method according to the present invention the double bond is reduced in the 1,2position of 3,4-dihydropyrrolo-[1 ,2-a]-pyrazine with the formation of I ,2,3,4-tetrahydropyrrolo [ 1 ,2-a]-pyrazine.
The synthesis of 1 ,2,3,4-tetrahydropyrrolo [1,2-a]-pyrazine is conducted in accordance with the following scheme:
As it is seen from the structural formula of 3,4dihydropyrrolo-[ 1 ,2,a]-pyrazine, it contains three double bonds, two of them belong to the pyrrol part of the heterocycle and the third double bond is conjugated with the pyrrol system and may be regarded as a double bond in a Schiff's base.
Under the conditions of the method according to the present invention only one double bond is reduced in the position 1,2 of the heterocycle without, however, involving in reduction the double bonds of the pyrrol part of the heterocycle.
In reduction with lithium alumohydride as a solvent use is generally made of ethers.
The method according to the present invention, wherein lithium alumohydride is used, proceeds quite weli in diethyl ether extensively used for such purposes. In this connection, the most preferable temperature range has, as its upper limit, the boiling point of diethyl ether and, thus is 25 to 360C.
In reduction with potassium or sodium boronhydrides as the solvents use is generally made of lower aliphatic alcohols. Since it is advisable to use methanol and ethanol as readily available alcohols, the reduction process in these cases should be preferably carried out repsectively St the boiling temperature of said solvents (i.e. within the range of from 65 to 800 C).
The resulting 1 ,2,3,4-tetrahydropyrrolo-[1 ,2- a]-pyrazine may be used as an intermediate product for the synthesis of physiologically active compounds.
An advantage of the use of 1,2,3,4- tetrahydropyrrolo-[1 ,2-a]-pyrazine as an intermediate product resides in the possibility of performing, on a commercial scale, the process of producing octahydropyrrolo-[l ,2-a]-pyrazine.
Moreover, the method for preparing 1,2,3,4tetrahydropyrrolo-[1 ,2-a]-pyrazine is simple in implementation, since as the starting stock for its synthesis use is made of 3,4-dihydropyrrolo[-1 ,2a]-pyrazine which, in turn, is obtained from readily available furfurol.
The method for preparing 1,2,3,4 tetrahydropyrrolo[1 ,2-a]-pyrazine is technologically simple and may be performed in the following manner.
The starting product, i.e. 3,4dihydropyrrolo [1,2-a]-pyrazine is prepared by reacting dialkylacetals or dioxalane of 2,5dialkoxytetrahydrofurfurol with ethylenediamine in a medium of lower aliphatic acids at a temperature within the range of from 100 to 1500, followed by isolation of the desired product by conventional techniques.
The reaction proceeds according to the following scheme:
wherein R,=R2=R3=CH3, or R =R2=R3=C2H5, or
R,=CH3, R2, R3=CH2CH2.
The resulting 3,4-dihydropyrrolo-[1,2-a]- pyrazine is dissolved in an organic solvent and reduced by one of the following methods.
In the case of using the method ot catalytic hydrogenation, the reduction process is conducted at room temperature under atmospheric pressure in the presence of the platinum group catalysts. The process is conducted under stirring in a closed system in a solution of a lower aliphatic alcohol in the atmosphere of hydrogen. The process speed depends on the character of the catalyst employed. After absorption of the theoretical amount of hydrogen, the catalyst is filtered-off, the solvent is distilled-off from the filtrate and the desired product is purified by distillation in vacuum.
Upon reduction by means of potassium boron hydride the process is preferably performed under stirring at a temperature within the range of from 65 to 800C in solutions of lower aliphatic alcohols. The process speed depends on the temperature at which the process is performed.
Isolation of the desired product is effected by addition of water to the reaction mixture and a subsequent extraction of the product with benzene. After distilling-off the solvent, the desired product is purified by distillation in vacuum.
In reduction by means of lithium alumohydride the process is preferably conducted under stirring at a temperature within the range of from 25 to 360C in a solution of diethyl ether. The process speed depends on the temperature at which the process is performed. Isoiation of the desired product isseffected by means of decomposition of the reaction mixture with water and/or aqueous alkali and separation of the ethereal solution by decantation. After distilling-off the solvent, the desired product is purified by distillation in vacuum.
For a better understanding of the present invention some specific Examples are given hereinbelow by way of illustration.
Example 1
Into a 0.5 1 single-neck flask provided with a magnetic stirrer there are charged 36 g of 3,4 dihydropyrrolo-[1 ,2-a]-pyrazine, 250 ml of absolute methanol and 1 g of a 10% Pd/BaSO4.
The flask is then connected with the source of hydrogen supply. To remove air, the reaction mass is purged with hydrogen and then allowed to stay in the atmosphere of hydrogen under stirring until the theoretical amount of hydrogen is absorbed. This theoretical amount of hydrogen is absorbed for 3 hours. As a result, the reaction mixture is obtained, wherefrom the catalyst is withdrawn by filtration. From the filtrate the solvent is distilled-off, the residue is distilled in vacuum collecting the fraction with the boiling point of 100--101 OC/7 mm Hg. The yield of 1 ,2,3,4-tetrahydrnpyrrolo-[1 ,2-a]-pyrazine is 34 g (95% of the theory), n2D0 is 1.5530. Found , %: C 68.49; H 8.15; C7H10N2. Calculated, %; C 68.82;
H 8.25.
Maleate is prepared by combining solutions of the resulting product and maleic acid (in the molar ratio of 1:1.1 respectively) in ethanol.
Melting point is 151--1520C (from aqueous ethanol). Found, %: C 55.50; H 6.04; N' 1.87.
C"H,4N204. Calculated, %: C 55.46; H 5.92; N 11.76.
Example 2
Into a 50 ml one-neck flask provided with a magnetic stirrer there are charged 2.4 g of 3,4 dihydropyrrolo-[1 ,2-a]-pyrazine, 20 ml of ethanol and 0.2 g of platinum oxide. Further stages of the process of reduction and recovery of the desired product are performed following the procedure described in the foregoing Example 1. The theoretical amount of hydrogen is absorbed for one hour.
The yield of the desired product is 2.2 g (92% of the theory). Constants and results of analysis of the thus-prepared compound are similar to those described in Example 1.
Example 3
Into a 100 ml two-neck flask provided with a stirrer and a reflux condenser there are charged 6 g of 3,4-dihydropyrrolo-[1 ,2-a]-pyrazine in 50 ml of ethanol and 5.4 g of potassium boronhydride.
The reaction mixture is kept for 6 hours under stirring at room temperature. Then the reaction mass is poured into water and the desired product is extracted with benzene. The solvent is distilledoff, the residue is distilled in vacuum and the fraction with the boiling point of 100--101 OC/7 mm Hg is collected.
The yield is 5.2 g (85% of the theoretical value), n2g=1.5525. The results of analysis of the thus-prepared compound are identic to those for the compound prepared in the foregoing Example 1.
Example 4
The desired product is prepared following the procedure of Example 3 hereinabove, except that the reaction mixture is heated at the temperature of 780C for 2 hours. The yield of the desired product is 79% of the theoretical value. The constants and results of analysis of the thusprepared product are identic to those of the compound described in Example 1 hereinbefore.
Example 5
Into a three-neck 250 ml flask provided with a stirrer reflux condenser and a dropping funnel there are charged 2.28 g of lithium alumohydride in 50 ml of absolute diethyl ether and then a solution of 3.6 g of 3,4-dihydropyrrolo-[1 ,2-a]pyrazine in 50 ml of absolute diethyl ether are drop-wide added thereto. The reaction mixture is stirred for 4 hours at room temperature and then successively added with 2.3 ml of water, 1.7 ml of a 40% caustic soda and 8 ml of water. The ethereal solution is separated by decantation. The ether is distilled-off, the residue is evaporated with benzene and distilled in vacuum and the fraction with the boiling point of 100--101 OC/7 mm Hg is collected.
The yield is 3.2 g (87% of the theoretical value), n2D=1.5522. The results of analysis of the thus-prepared compound are similar to those for the compound described in Example 1 hereinbefore.
Example 6
The desired product is prepared following the procedure of the foregoing Example 5, except that the reaction mixture is heated at reflux at the temperature of 36OC for one hour. The yield of the desired product is 83% of the theoretical value. The constants and results of analysis of the thus-prepared compound are identic to those for the compound described in Example 1 hereinabove.
Claims (7)
1.1,2,3,4-Tetrahydropyrrolo-[1,2-a]-pyrazine of the formula:
2. A method for preparing 1,2,3,4 tetrahydropyrrolo-[l ,2-a]pyrazine according to Claim 1, comprising reducing, 3,4-dihydropyrollo- [1,2-a]-pyrazineTn a medium of an organic solvent by hydrogenation thereof with hydrogen or complex hydrides of metals, in the case of
using hydrogen the hydrogenation being effected
in the presence of a platinum-group catalyst, followed by isolation of the desired product from the resulting reaction mixture.
3. A method according to Claim 2, wherein as the complex hydrides of metals use is made of
potassium boronhyride or lithium alumohydride.
4. A method according to Claims 2, 3, wherein in the case of using potassium boronhydride, the reduction is effected in a medium of lower aliphatic alcohols at a temperature within the range of from 65 to 80cC.
5. A method according to Claims 2 and 3, wherein in the case of using lithium alumohydride, the reduction is effected in diethyl ether at a temperature within the range of from 25 to 360C.
6. A method according to the foregoing Claims 2 to 5, substantially as described in the
Specification and Examples 1 to 6 given hereinbefore.
7. 1 ,2,3,4-Tetrahydropyrrolo-[l ,2-a]-pyrazine, whenever prepared by the method substantially as described in any of the foregoing Claims 2 to 6.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB7830788A GB2025936B (en) | 1978-07-22 | 1978-07-22 | 1,2,3,4 - tetrahydropyrrolo - (1,2 - ) - pyrazine and method for preparing same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB7830788A GB2025936B (en) | 1978-07-22 | 1978-07-22 | 1,2,3,4 - tetrahydropyrrolo - (1,2 - ) - pyrazine and method for preparing same |
Publications (2)
Publication Number | Publication Date |
---|---|
GB2025936A true GB2025936A (en) | 1980-01-30 |
GB2025936B GB2025936B (en) | 1982-10-27 |
Family
ID=10498592
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB7830788A Expired GB2025936B (en) | 1978-07-22 | 1978-07-22 | 1,2,3,4 - tetrahydropyrrolo - (1,2 - ) - pyrazine and method for preparing same |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2025936B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994029315A1 (en) * | 1993-06-11 | 1994-12-22 | The Russian-American Institute For New Drug Development | 1,2,3,4-TETRAHYDROPYRROLO[1,2-a]PYRAZINES |
-
1978
- 1978-07-22 GB GB7830788A patent/GB2025936B/en not_active Expired
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994029315A1 (en) * | 1993-06-11 | 1994-12-22 | The Russian-American Institute For New Drug Development | 1,2,3,4-TETRAHYDROPYRROLO[1,2-a]PYRAZINES |
US5378846A (en) * | 1993-06-11 | 1995-01-03 | Russian-American Institute For New Drug Development | 1,2,3,4-tetrahydropyrrolo-[1,2-a]-pyrazine derivatives |
Also Published As
Publication number | Publication date |
---|---|
GB2025936B (en) | 1982-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sasaki et al. | Studies on hetero-cage compounds—VI: Transannular cyclizations in pentacyclo [6.2. 1.0. 2, 70.4, 1005, 9] undecan-3, 6-dione system | |
HU198437B (en) | Process for producing mono- or bis-carbonyl-compounds | |
Eliel et al. | Convenient and stereoselective dithiol synthesis | |
US4230856A (en) | 1,2,3,4-Tetrahydropyrrolo-[1,2-a]-pyrazine | |
GB2025936A (en) | 1,2,3,4-Tetrahydropyrrolo-[1,2-a]- pyrazine and Method for Preparing Same | |
CN114950545B (en) | Oxazolium catalyst for acetaldehyde acyloin condensation reaction, and preparation method and application thereof | |
Herz et al. | Glycosidic disecoeudesmanolides and other secosesquiterpene lactones from Picradeniopsis species. X-ray analysis of bahia I | |
Warnhoff | New rearrangements of the caryophyllene skeleton: The dinitrophenylhydrazones from caryophyllene oxide | |
GB1564807A (en) | Cholestene derivatives | |
US3328426A (en) | Process for the manufacture of cyclic ethers | |
Johnson et al. | Asymmetric chemistry. Alcohol effects upon the (+)-1, 2, 2-trimethyl-1, 3-bis (hydroxymethyl) cyclopentane-lithium aluminum hydride reduction of acetophenone | |
Tada et al. | Reaction of (3-Furylmethyl) cobaloxime with Dienophiles. Variable Mode of the Reaction by the Type of Dienophiles | |
CA1152087A (en) | Aryl-substituted furanes, and process for their production | |
US3896150A (en) | 2,6,10-trimethyldodeca-2,6,11-trien-10-ol-1-al-2,6-dimethyl-2,6-undecadien-10-on-1-al and their acetals and processes for their production | |
Field et al. | Synthesis of. alpha.-dehydrobiotin | |
US4511718A (en) | Preparation of pyrazine derivatives | |
Pelletier et al. | An unusual oxidation of an N CH3 group to an N CHO group by osmium tetroxide | |
Fréchet et al. | Use of Polymers as Protecting Groups in Organic Synthesis. VII. Preparation of Monobenzoates of Acyclic Triols | |
US3726872A (en) | Aminomethylbicyclononenes and dihydro derivatives thereof | |
Adams et al. | Senecio Alkaloids: Mikanoidine, the Alkaloid from Senecio mikanoides | |
MEYERS et al. | A New Approach to Polycyclic Bases. II. 1-Azabicyclo [4.3. 0] nonanes, 1-Azabicyclo [3.3. 0] octanes, and Related Systems1, 2 | |
US2884464A (en) | Process for the production of allyl substituted acetylene compounds | |
US3068234A (en) | Preparation of 16-oxo-isomorphinan | |
Szarek et al. | Lycopodium Alkaloids: XVI. Annotine | |
JPS584695B2 (en) | Method for producing cyclopentenone derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |